Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer

Lymphology

Volumn 32, Issue 1, 1999, Pages 3-10

  Burgos, Angel ^a   Alcaide, A ^b   Alcoba, C ^c   Azcona, J M ^d   Garrido, J ^a   Lorente, C ^g   Moreno, E ^g   Murillo, E ^g   Olsina Pavia, J ^b   Olsina Kissler, J ^b   Samaniego, E ^e   Serra, M ^f  

^a Laboratorios Knoll SA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e Instituto Oncologico   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g Laboratorios Knoll SA ^*

Author keywords

[No Author keywords available]

Indexed keywords

CINITAPRIDE; COUMARIN ANTICOAGULANT; DIPYRONE; RANITIDINE;

ADULT; ARM EDEMA; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VAGINA BLEEDING;

ARM; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LYMPHEDEMA; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032946857     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Calitchi, E, JM Cheula, Y Otmezguine, et al: Analyse restrospective a 10 ans des sequelles du traitment loco-regional des cancers du sein. Bull. Cancer 71 (1984), 100-104.
2. Pecking, A: Traitement medical du lymphoedeme par les benzopyrones. Bases expérimentales et applications. J. Malad. Vasc. 15 (1990), 157-158.
3. Clarysse, A: Lymphoedema following breast cancer treatment. Acta Clin. Belg. Suppl. 15 (1993), 47-50.
4. Serra, M, M Ferrer, P Morant, et al: Protocolo diagnóstico y terapéutico del linfedema. Rehab. Fis. 3 (1992), 10-14.
5. Bolton, T, JR Casley-Smith: An in vivo demonstration of proteolysis by macrophages and its increase with coumarin. Experientia 31 (1975), 271-272.
6. Piller, NB: Drug-induced proteolysis: A correlation with oedema-reducing ability. Br. J. Exp. Pathol. 57 (1976), 266-273.
7. Piller, NB: Further evidence for the induction of proteolysis by coumarin in rats with various high-protein oedemas. Arzneim. Forsch. 27 (1977), 860-864.
8. Piller, NB: The influence of various benzopyrones on acid and neutral protease activity levels, the cells form which they may arise and their importance in the resolution of lymphoedema. Res. Exp. Med. 170 (1977), 115-124.
9. Mislin, H: Die Wirkung von cumarin aus Melilotus officinalis auf die funktion des lymphangions. Arzneim. Forsch. 21 (1971), 852-853.
10. Overman, RS, MA Stahmann, CF Huebner, et al: Studies on the hemorrhagic sweet clover disease. Anticoagulant activity and structure in the 4-hydroxycoumarin group. J. Biol. Chem. 153 (1944), 5-24.
11. Piller, NB, L Clodius: The use of a tissue tonometer as a diagnostic aid in extremity lymphoedema: A determination of its conservative treatment with benzo-pyrones. Lymphology 9(1976), 127-132.
12. Clodius, L, NB Piller: Conservative therapy for postmastectomy lymphedema. Chir. Plastica 4 (1978), 193-202.
13. Beinssen, APA: Possible coumarin hepatotoxicity. Med. J. Aust. 161 (1994), 725.
14. Bassett, ML, JE Dahlstrom: Liver failure while taking coumarin. Med. J. Aust. 163 (1995), 106.
15. Morrison, L, PD Welsby: Side-effects of coumarin. Postgrad. Med. J. 71 (1995), 701-702.
16. Ritschel, WA, KA Hoffmann: Pilot study on the bioavailability of coumarin and 7-hydroxycoumarin upon peroral administration of coumarin in a sustained release dosage form. Clin. Pharmacol. 21 (1981), 294-301.
17. th International Congress of Lymphology Working Group discussions and recommendations. Lymphology 18 (1985), 175-180.
18. Fischbach, JU, B Mönter, E Göltner: Messungen von armödemen durch optoelektronische volumetrie. Phlebol. Proktol. 15 (1986), 184-189.
19. Pecking, A, R Cluzan: Etude de l'action du lysedem dans le traitement médical des lymphoedemes secondaires aux traitements des cancers du sein. Phlebologie (1989), 591-593.
20. Casley-Smith, JR, JR Casley-Smith: High-protein oedemas and the benzopyrones. JB Lippincott, Australia, 1986.
21. th International Congress of Lymphology. Casley-Smith, JR, NB Piller (Eds.), University of Adelaide Press, Australia, 1985.
22. Casley-Smith, JR, RG Morgan, NB Piller: Treatment of lymphedema of the arms and legs with 5,6-benzo-[alfa]-pyrone. New Engl. J. Med. 329 (1993), 1158-1163.
23. Lafontan, B, JM Dilhuidy, A Monnier, et al: Intérêt de la coumarine associé à la physiothérapie dans le traitement du lymphoedème du membre supérieur après cancer du sein: Étude sur 1 an. Bull. Cancer Radiother. 78 (1991), 119-124.
24. Cox, D, R O'Kennedy, RD Thornes: The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Human Toxicol. 8 (1989), 501-506.